These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35476750)

  • 1. Hepatic GSK3β-Dependent CRY1 Degradation Contributes to Diabetic Hyperglycemia.
    Kim YY; Jang H; Lee G; Jeon YG; Sohn JH; Han JS; Lee WT; Park J; Huh JY; Nahmgoong H; Han SM; Kim J; Pak M; Kim S; Kim JS; Kim JB
    Diabetes; 2022 Jul; 71(7):1373-1387. PubMed ID: 35476750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
    Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
    Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
    Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
    Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
    Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1.
    Toledo M; Batista-Gonzalez A; Merheb E; Aoun ML; Tarabra E; Feng D; Sarparanta J; Merlo P; Botrè F; Schwartz GJ; Pessin JE; Singh R
    Cell Metab; 2018 Aug; 28(2):268-281.e4. PubMed ID: 29937374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO1 is downregulated in obese mice subjected to short-term strength training.
    Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
    Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Targets Foxo1 to Control Glucose Homeostasis.
    Guo X; Li X; Yang W; Liao W; Shen JZ; Ai W; Pan Q; Sun Y; Zhang K; Zhang R; Qiu Y; Dai Q; Zheng H; Guo S
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N; Tiwary S; Kesharwani D; Datta M
    J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
    Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
    Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
    J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis.
    Wu Y; Pan Q; Yan H; Zhang K; Guo X; Xu Z; Yang W; Qi Y; Guo CA; Hornsby C; Zhang L; Zhou A; Li L; Chen Y; Zhang W; Sun Y; Zheng H; Wondisford F; He L; Guo S
    Diabetes; 2018 Nov; 67(11):2167-2182. PubMed ID: 30201683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
    J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
    Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
    [No Abstract]   [Full Text] [Related]  

  • 18. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
    Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
    Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrobium huoshanense polysaccharide regulates hepatic glucose homeostasis and pancreatic β-cell function in type 2 diabetic mice.
    Wang HY; Li QM; Yu NJ; Chen WD; Zha XQ; Wu DL; Pan LH; Duan J; Luo JP
    Carbohydr Polym; 2019 May; 211():39-48. PubMed ID: 30824102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.